3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Recurrence
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Kidney Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
9
Papillomavirus Vaccines
8
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Surveys and Questionnaires
6
Educational Status
6
Blood Specimen Collection
5
Vaginal Smears
4
Radiotherapy, Intensity-Modulated
4
Methods
4
Human Papillomavirus DNA Tests
4
Early Intervention, Educational
4
Cisplatin
4
Carboplatin
4
Patient Navigation
3
Mass Screening
3
Taxes
2
Standard of Care
2
Radiation
2
Practice Guidelines as Topic
2
Papanicolaou Test
2
Paclitaxel
2
Motivational Interviewing
2
Interviews as Topic
2
Electrocoagulation
2
Docetaxel
2
Cytological Techniques
2
Cryotherapy
2
Colposcopy
2
utomilumab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Papillomavirus Infections
×
Receptor Protein-Tyrosine Kinases
×
Clear all
NCT01588301
2014-09-12
APACHE-2
University Hospital, Tours
Phase EARLY_PHASE1
Completed
5,998 enrolled